Richter Gedeon To Issue New Shares

4 May 1997

- The Richter Gedeon drugs producer in Hungary is to issue new sharesto a nominal value of 1 billion forint ($5.8 million), while the State Privatization and Holding Company will sell shares in the company worth a nominal 1.8 million forint, according to MTI Econews. Most shares will be offered via public subscription, but 200,000 shares with a nominal value of 200 million forint will be offered to private investors in Hungary. These investors will be able to pay half the share price immediately and the remainder within a year.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight